Off-Package Labeling For Small Cosmetic-Drugs Suggested By CTFA
This article was originally published in The Tan Sheet
Executive Summary
Off-package labeling of inactive ingredients for small, cartonless cosmetic-drug products should be allowed as a general exemption to FDA's OTC labeling final rule, the Cosmetic, Toiletry & Fragrance Association suggested during an agency-industry workshop in Rockville, Md. Sept. 17.
You may also be interested in...
Block Drug Small Package Labeling Exemption Denial Mishandled - CHPA
FDA erred in denying Block Drug's request for an exemption from the OTC labeling final rule, the Consumer Healthcare Products Association says in an Oct. 3 letter to the agency.
Block Drug Small Package Labeling Exemption Denial Mishandled - CHPA
FDA erred in denying Block Drug's request for an exemption from the OTC labeling final rule, the Consumer Healthcare Products Association says in an Oct. 3 letter to the agency.
Block Drug Small Package Labeling Exemption Denial Mishandled - CHPA
FDA erred in denying Block Drug's request for an exemption from the OTC labeling final rule, the Consumer Healthcare Products Association says in an Oct. 3 letter to the agency.